Kricorian Becomes Artes Chief Medical Officer

Artes Medical, Inc. a medical technology company which has a target of developing, making and commercializing a new category of aesthetic injectable products for both sex officially declared the appointment of Greg J. Kricorian, M.D. to the new office of Chief Medical Officer. ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of wrinkles called smile lines.

Dr. Greg Kricorian will report to Artes Medical's President and also to the Chief Executive Officer, Diane S. Goostree. He has the obligation of being responsible for the clinical development and medical affairs departments. In his new office, he will assume the role of the chairman of the Company's Medical
Advisory Board (MAB), and aim at enhancing the Company's participation in the medical community.

Greg Kricorian will play a key role in Artes Medical's newly formed wholly-owned subsidiary, Spheris Medical, Inc., which has the purpose of developing and commercializing new and innovative medical applications based on the Company's proprietary microsphere tissue bulking technology.

Greg has significant experience in the commercial development of dermatology products as well as in the design, execution and management of clinical studies of innovative aesthetic products, said Ms. Goostree.

Additionally, his strong relationships with the medical community will strengthen our management team as we move forward with our marketing launch campaign for ArteFill(R). she continued

The new Chief Medical Officer has over 10 years experience in the clinical and business development of cosmetic and aesthetic dermatology products. Before he joined Artes Medical, he served as Senior Director, Medical Affairs for a renowned pharmaceutical company, Valeant Pharmaceuticals International.

Dr. Kricorian got his Bachelor of Science in Biology from University of California, Los Angeles; his M.D. at Stanford University Medical School; and his Masters of Business Administration from the University of California, Los Angeles. Additionally, Dr. Kricorian received his Regulatory Affairs Certification
(RAC) from the Regulatory Affairs Professional Society.